- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Marksans Pharma Ltd (MARK)
Track today's live Marksans Pharma Ltd (MARK) share price, performance and key data on this page with our current NSE:MARK stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Marksans Pharma Ltd share price on the NSE exchange. Use the dropdown to switch exchange for the MARK share price, head to our technical summary section, which provides analysis on Marksans Pharma Ltd share price buy/sell indicators using real-time data (or discuss the Marksans Pharma Ltd (MARK) stock price today with other investors in the Marksans Pharma Ltd NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:MARK share price (ISIN: INE750C01026) to enhance your trading decisions with our free investment tools and resources.
What Is the Marksans Pharma Ltd Share Price Today?
The Marksans Pharma Ltd share price today is 286.90.
What Is the Stock Symbol for Marksans Pharma Ltd
The stock symbol (or 'ticker') for Marksans Pharma Ltd is "MARK."
What Stock Exchange Does Marksans Pharma Ltd Trade On?
Marksans Pharma Ltd is listed and trades on the NSE stock exchange.
Is Marksans Pharma Ltd a Good Stock to Buy?
Determining whether Marksans Pharma Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:MARK share price (ISIN: INE750C01026) to enhance your trading decisions with our free investment tools and resources.
What Is the Marksans Pharma Ltd Share Price Today?
The Marksans Pharma Ltd share price today is 286.90.
What Is the Stock Symbol for Marksans Pharma Ltd
The stock symbol (or 'ticker') for Marksans Pharma Ltd is "MARK."
What Stock Exchange Does Marksans Pharma Ltd Trade On?
Marksans Pharma Ltd is listed and trades on the NSE stock exchange.
Is Marksans Pharma Ltd a Good Stock to Buy?
Determining whether Marksans Pharma Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
286.90
-7.55(-2.56%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
282.70
295.35
52 wk Range
155.00
350.95
Earnings results expected in 9 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
282.70295.35
52 wk Range
155.00350.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MARKSANS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
324.33
Upside
+13.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Mankind Pharma shares get buy rating- Investing.com
- Mankind Pharma shares get buy rating
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 324.33
(+13.05% Upside)
Marksans Pharma Ltd Earnings Call Summary for Q1/2027
- Marksans Pharma Q1 FY27 revenue rose 35.6% YoY to INR 840.8 crores, but missed forecast of $8.88B by 4.28%; stock fell 3.07% to $303.
- EBITDA more than doubled to INR 213 crores (25.3% margin); PAT surged 173.9% to INR 159.4 crores, both quarterly records.
- Europe revenue jumped 74.7% YoY to INR 356 crores; cash balance exceeded INR 1,000 crores for first time, reaching INR 1,058 crores.
- FY27 guidance unchanged at 15-20% revenue growth, 20-21% EBITDA margin due to geopolitical uncertainty and cost pressures.
- Management expects Q3 to be strongest quarter; gross margin to normalize to 55-56% from 59.1% as inventory benefits fade.
Last Updated: 13/08/2026, 13:14
Read Full TranscriptEarnings
Latest Release
12/08/2026
EPS / Forecast
3.45 / --
Revenue / Forecast
8.41B / 8.88B
Compare MARKSANS to Peers and Sector
Metrics to compare | MARKSANS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMARKSANSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.2x | 23.6x | −0.3x | |
PEG Ratio | 0.53 | 0.25 | 0.00 | |
Price/Book | 4.3x | 3.1x | 2.6x | |
Price / LTM Sales | 4.1x | 3.5x | 2.9x | |
Upside (Analyst Target) | 13.0% | 16.3% | 65.4% | |
Fair Value Upside | Unlock | 9.6% | 8.9% | Unlock |
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Marksans Pharma Ltd (NSE: MARKSANS) Share Price Today?
The Marksans Pharma Ltd stock price today is 286.90 INR.
What Stock Exchange Does Marksans Pharma Ltd (MARKSANS) Trade On?
Marksans Pharma Ltd is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Marksans Pharma Ltd?
The stock symbol (also called a 'ticker') for Marksans Pharma Ltd is "MARKSANS."
Does Marksans Pharma Ltd Pay Dividends? What’s The Current MARKSANS Dividend Yield?
Yes, MARKSANS Pays Dividends to its Shareholders. The current Marksans Pharma Ltd dividend yield is 0.3%%.
What Is the Current Marksans Pharma Ltd Market Capitalisation?
As of today, Marksans Pharma Ltd (NSE: MARKSANS) market cap is 130.01B INR.
What Is Marksans Pharma Ltd's (MARKSANS) Earnings Per Share (TTM)?
The Marksans Pharma Ltd EPS is currently 11.40 (Trailing Twelve Months).
When Is the Next Marksans Pharma Ltd Earnings Date?
Marksans Pharma Ltd's next earnings report will be released on 04/11/2026.
Is MARKSANS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Marksans Pharma Ltd moving averages and other technical indicators, the daily buy/sell signal for MARKSANS stock is Strong Sell.
How Many Times Has Marksans Pharma Ltd Stock Split?
Marksans Pharma Ltd has split 1 times. (See the MARKSANS stock split history page for full effective split date and price information.)
How Many Employees Does Marksans Pharma Ltd Have?
Marksans Pharma Ltd has 1685 employees, based on their latest Companies House report.
What is the current trading status of Marksans Pharma Ltd (NSE: MARKSANS)?
As of 26/10/2026, Marksans Pharma Ltd (MARKSANS) is trading at a share price of 286.90 INR, with a previous close of 286.90 INR. The stock has fluctuated within a day range of 282.70 INR to 295.35 INR, while its 52-week range spans from 155.00 INR to 350.95 INR.
What Is Marksans Pharma Ltd (MARKSANS) Price Target According to Analysts?
The average 12-month price target for Marksans Pharma Ltd is 324.33 INR, with a high estimate of 385 INR and a low estimate of 210 INR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +13.05% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.